Withdrawal of Registration Statement (rw)
and Exchange Commission
of Corporate Finance
F Street, N.E.
Premier Biomedical, Inc.
Registration Statement on Form S-1
Filed December 10, 2019
File No. 333-235434
Request for Withdrawal
Pursuant to Rule 477 of the Securities Act of
1933, as amended (the “Securities
Act”), Premier Biomedical, Inc.
(the “Company”) respectfully requests that the Securities and
Exchange Commission (the “Commission”) consent to the withdrawal of the Company’s
Registration Statement on Form S-1 (File
No. 333-235434), together with all exhibits thereto (the
Statement”), with such
withdrawal to be effective as of the date hereof or as soon as
practicable hereafter. The Registration Statement was filed with
the Commission on December 10, 2019 and was not declared
Consistent with the public interest and the
protection of investors contemplated by paragraph (a) of Rule
477 of the Securities Act, the
Company is withdrawing this Registration Statement in response to
communications with the Commission’s staff. The Company intends to
file a new registration statement on Form S-1 to replace the
Registration Statement. The Company confirms that no securities
were sold in connection with the offering.
Company further requests, in accordance with Rule 457(p) of the
Securities Act, that all fees paid to the Commission in connection
with the filing of the Registration Statement be credited to the
Company’s account with the Commission for future use.
you have any questions regarding this matter, please contact the
Company’s counsel, Brian A. Lebrecht of Clyde Snow & Sessions,
P.C., at (801) 433-2453.
William A. Hartman